HEARING News & Analysis

The early negative market reaction to Cochlear's half-yearly result is overdone and ignores solid growth in hearing implant upgrades, says...

Hearing implant company Cochlear says its profits have risen 16 per cent to $128.6 million, but its shares have plunged after it said its growth in...

Biotech stock Cochlear has kicked off the next phase of implant technology as the healthcare sector takes a tumble.